Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
G1 Therapeutics, Inc. See All Filings	D/A	2016-07-01 16:20:38 UTC
Amount To Be Raised $50,000,000 Associated Brokers / Dealers N/A CIK Number 0001560241 Filed Document 0001560241-16-000005 Exclusions or Exemptions 506b Accepted Date 2016-07-01 16:20:38 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
G1 Therapeutics, Inc. See All Filings	D	2016-05-11 00:00:00 UTC
Amount To Be Raised $50,000,000 Associated Brokers / Dealers N/A CIK Number 0001560241 Filed Document 0001560241-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-05-11 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
G1 Therapeutics, Inc. See All Filings	D	2015-02-12 00:00:00 UTC
Amount To Be Raised $33,011,989 Associated Brokers / Dealers N/A CIK Number 0001560241 Filed Document 0001560241-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-02-12 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
G1 Therapeutics, Inc. See All Filings	D/A	2014-06-23 00:00:00 UTC
Amount To Be Raised $12,597,221 Associated Brokers / Dealers N/A CIK Number 0001560241 Filed Document 0001560241-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-06-23 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity
G1 Therapeutics, Inc. See All Filings	D	2013-10-14 00:00:00 UTC
Amount To Be Raised $12,597,221 Associated Brokers / Dealers N/A CIK Number 0001560241 Filed Document 0001560241-13-000007 Exclusions or Exemptions 506b Accepted Date 2013-10-14 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NORTH CAROLINA Revenue or Assets Decline to Disclose Type of Security Equity